|
Paula M. Jardieu is currently the Senior Vice President, Biosciences Division at Prevalere Life Sciences in Whitesboro, NY, where she oversees departments responsible for contract drug development, strategic planning for Pharmatox and PK study design for IND applications, and clinical pharmacology/clinical pharmacokinetic study design and implementation. Dr. Jardieu is also a voting member of the Executive Committee which manages operating and capital budgets. Prior to Prevalere, Dr. Jardieu worked for Genentech, Inc. in San Francisco, CA, where she held positions of increasing responsibility. She was the Senior Vice President of Development Sciences from 2000-2002, Vice President of Pharmacological Sciences from 1997-2000, Senior Director of Pharmacological Sciences from 1996-1997, and a Research Staff Scientist from 1992-1997. While at Genentech, Dr. Jardieu was the Project Team Leader for Xolair from IND filing through initiation of Phase III, and Project Team Leader for Raptiva through IND filing. From 1985-1986, she was a Research Associate at Johns Hopkins University School of Medicine: Department of Molecular Biology and Genetics-Immunology and a Post-Doctoral Fellow from 1982-1985. Dr. Jardieu has numerous publications and professional memberships. She has been the recipient of a number of awards and honors. Dr. Jardieu received her B.A. in Chemistry from Albion College, Albion, MI in 1975, her M.S. Biochemistry from Michigan State University in East Lansing, MI in 1979, and her Ph.D. in Microbiology from Michigan State University in 1982.
| 